AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2022
Sep 16, 2022
34395_dirs_2022-09-16_2d270106-0394-44e4-a003-b6a520fb56ad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-08-23-05:00
Reporting Person: Butera Salvatore Thomas (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 135000 | Direct |
| Common Stock | 37000 | Direct |
Footnotes
F1: On November 18, 2021, June 17, 2022, August 23, 2022 and August 24, 2022, the reporting person filed certain Form 4's reporting the market purchase of an aggregate of 30,000 shares of common stock. The reporting person inadvertently omitted to disclose that these shares were purchased jointly with his spouse.
F2: These shares of common stock are jointly owned by the reporting person and his spouse.
More from VOLITIONRX LTD
Capital/Financing Update
2026
Jun 9
Capital/Financing Update
2026
Jun 9
Capital/Financing Update
2026
Jun 5
Proxy Solicitation & Information Statement
2026
Jun 2
Capital/Financing Update
2026
May 22
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 14
Report Publication Announcement
2026
May 14
Proxy Solicitation & Information Statement
2026
May 13
Annual Report
2026
Apr 30